Diaccurate is a spin off from INSTITUT PASTEUR PARIS FRANCE. We work on a new enzymatic mechanism involved in the control of immune responses against HIV and other pathogens. Involvement of this mechanism in the control of tumor growth is also under study. In the plasma of immunodeficient patients we discovered a new molecule named RIF (for “Refractory state Inducing Factor”) which by modifying their membrane blocks specifically CD4 lymphocytes responses. Inhibitory monoclonal antibody neutralizing RIF have been characterized and clinical trials should start in 2019.
We plan to recruit highly motivated post docs for working in the biochemical aspects of the mechanisms involved. Solid competences in biochemistry are mandatory as confirmed by high level of international publications and two supporting letters. Knowledge in cellular and molecular immunology would be appreciated.
Jobs are located in Paris. Contracts will be from two to four years. Salary: 60 000 € – 70 000 € / years. Starting date: November 1 / 2018.
Send application to Eleonore.firstname.lastname@example.org